Satellite Bio
Cambridge
About Satellite Bio
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $101.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2022)
- Website: satellite.bio
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/satellite-bio-15863 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.